Functional Concept – Page 29

Aurion Biotech, Alcon Research, Deerfield Management , Initial Public Offering (IPO), Legal dispute, Biotech industry, Corporate governance, Shareholder rights, Delaware Court of Chancery

Pfizer Discontinues Hemophilia B Gene Therapy Beqvez, Exits Gene Therapy Field

6 months ago talkbio0Tagged Beqvez, Discontinuation (procedure), Exit, gene therapy, Hemophilia B, Pfizer, portfolio

Pfizer, Beqvez, hemophilia B, gene therapy, discontinuation, portfolio exit

Entrada given go-ahead to test DMD therapy after two-year hold

6 months ago talkbio0Tagged Adult, DMD, Entrada, Exons, Muscular Dystrophy, Duchenne, United States Food and Drug Administration

Entrada, Muscular Dystrophy, Duchenne, DMD, United States Food and Drug Administration, Adult, Exons

FDA Approves Label Changes for Indivior’s Sublocade, Enhancing Treatment Accessibility for Opioid Use Disorder

6 months ago talkbio0Tagged Alternative, Approved, Diabetic monitoring - injection sites, initiation protocol, Opioids, Sublocade, United States Food and Drug Administration

Sublocade, FDA approval, rapid initiation protocol, alternative injection sites, opioid use disorder treatment

FDA Lifts Clinical Hold on Entrada’s Duchenne Muscular Dystrophy Drug ENTR-601-44 After Two Years

6 months ago talkbio0Tagged ELEVATE-44, ENTR-601, Entrada, exon, Muscular Dystrophy, Duchenne, Phase 1b Trial, skipping, Study on Hold, United States Food and Drug Administration

Duchenne muscular dystrophy, ENTR-601-44, Entrada Therapeutics, FDA, clinical hold, exon 44 skipping, ELEVATE-44-102, Phase 1b trial